The future of asthma management: scientific questions that need to be addressed
| How are acute and chronic oral corticosteroids managed once biologics are initiated in a real-life setting? |
| How should a second-line biological treatment be chosen if a patient fails with first-line respiratory biological therapy? |
| What are the different sub-phenotypes of non-eosinophilic asthma? |
| Can the natural course of the disease be modified by early intervention with anti-interleukin-5? |
| What is the effect of biological therapies on airway remodelling? |
| Could there be a beneficial impact of biologics on the cost of treatment through home care delivery in the severe asthma population? |
| What real-life factors could be used to distinguish between high and low responders to biologics? |
| What is the effect of using biologics in an acute asthma setting? |